Asian Journal of Pharmaceutical Research and Health Care

Open Access Open Access  Restricted Access Subscription Access

Method Development and Validation for Estimation of Tinofovir Disoproxil Fumarate in Pharmaceutical Preparation by UV-Spectroscopy and HPLC with Force Degradation Study


Affiliations
1 Department of Pharmaceutical Sciences, Mewar University, Chittorgarh − 312901, Rajasthan, India
2 Amrutvahini College of Pharmacy, Savitribai Phule Pune University, Pune − 422605, Maharashtra, India
 

Tinofovir Disoproxil Fumarate (TDF) is an acyclic nucleotide diester analog of adenosine monophosphate from the antiviral category utilized in the AIDS and hepatitis B treatment. In the present study, two analytical methods, i.e. UV and HPLC were developed for the TDF’s estimation in pharmaceutical preparation. In the UV method, the mobile phase used was Methanol and water in 60:40 ratio for estimation of the drug at 260 nm and an assay of the (TDF) obtained was 99.53%. The method’s validation was carried out as per ICH Q2 R1 guidelines in which linearity was detected from 10-50 µg/ml range with a regression value of 0.999 Percent RSD value of accuracy, precision and robustness were below 2. In the HPLC method estimation of (TDF) was evaluated on Cosmosil C-18 (250mm×4.6ID, Particle size: 5 µ) column utilizing Methanol: Water (60:40), 0.9 ml/min of flow rate, detection wavelength was 260 nm and the time of retention observed was around 4.63 minutes with the assay value 99.07%. HPLC method was also validated according to ICH guidelines, where linearity was detected in the 10-50 μg/ml of range with the regression coefficient value 0.999. The % RSD of precision, accuracy, and robustness was below 2%. The study of forced degradation was also performed by the HPLC method utilizing methanol: water (60:40) at 260nm. From this study, it can be concluded that the developed methods for estimation of (TDF) drug in pharmaceutical preparation are simple, accurate, precise, and can be utilized in the routine analysis for quantification of the drug in a dosage form.


Keywords

Force Degradation Study, HPLC, Tinofovir Disoproxil Fumarate, UV, Validation
User
Notifications
Font Size

  • Delaney WE, Ray AS, Yang H, Qi X, Xiong S, Zhu Y, Miller MD. Intracellular metabolism and in vitro activity of TDF against hepatitis B virus. Antimicrobial Agents and Chemotherapy. 2006 Jul 1; 50(7):2471-2477. https:// doi.org/10.1128/AAC.00138-06. PMid: 16801428, PMCid: PMC1489769.

  • Aloy B, Tazi I, Bagnis CI, Gauthier M, Janus N, LaunayVacher V, Deray G, Tourret J. Is TDF alafenamide safer than TDF disoproxil fumarate for the kidneys? AIDS Rev. Oct-Dec 2016; 18(4):184-192. https://pubmed.ncbi.nlm.nih.gov/27438578/. PMID: 27438578.

  • Kearney BP, Flaherty JF, Shah J. TDF disoproxil fumarate. Clinical Pharmacokinetics. 2004 Aug 1; 43(9):595-612. https://doi.org/10.2165/00003088-200443090-00003. PMid: 15217303.

  • Kearney BP, Yale K, Shah J, Zhong L, Flaherty JF. Pharmacokinetics and dosing recommendations of TDF disoproxil fumarate in hepatic or renal impairment. Clinical Pharmacokinetics. 2006 Nov 1; 45(11):11151124. https://doi.org/10.2165/00003088-200645110-00005. PMid: 17048975.

  • Fernandez-Fernandez B, Montoya-Ferrer A, Sanz AB, Sanchez-Nino MD, Izquierdo MC, Poveda J, Sainz-Prestel V, Ortiz-Martin N, Parra-Rodriguez A, Selgas R, Ruiz-Ortega M. TDF nephrotoxicity: 2011 update. AIDS Research and Treatment. 2011. https://doi.org/10.1155/2011/354908.

  • PMid: 21716719, PMCid: PMC3119412.

  • Kearney BP, Sayre JR, Flaherty JF, Chen SS, Kaul S, Cheng AK. Drug‐drug and drug‐food interactions between TDF disoproxil fumarate and didanosine. The Journal of Clinical Pharmacology. 2005 Dec; 45(12):1360-1367. https://doi.org/10.1177/0091270005281351. PMid: 16291710.

  • Wood R. Atazanavir: Its role in HIV treatment. Expert Review of Anti-Infective Therapy. 2008 Dec 1; 6(6):785796. https://doi.org/10.1586/14787210.6.6.785. PMid: 19053892, PMCid: PMC3805961.

  • Kandagal PB, Manjunatha DH, Seetharamappa J, Kalanur SS. RP‐HPLC method for the determination of TDF in pharmaceutical formulations and spiked human plasma. Analytical Letters. 2008 Mar 1; 41(4):561-570. https://doi.org/10.1080/00032710801910742.

  • Sharma R, Mehta K. Simultaneous spectrophotometric estimation of TDF disoproxil fumarate and lamivudine in three component tablet formulation containing efavirenz. Indian Journal of Pharmaceutical Sciences. 2010 Jul; 72(4):527. https://doi.org/10.4103/0250-474X.73926.

  • PMid: 21218073, PMCid: PMC3013570.

  • Bhavsar DS, Patel BN, Patel CN. RP-HPLC method for simultaneous estimation of TDF disoproxil fumarate, lamivudine, and efavirenz in combined tablet dosage form. Pharmaceutical Methods. 2012 Jul 1; 3(2):73-78. https:// doi.org/10.4103/2229-4708.103876. PMid: 23781482, PMCid: PMC3658085.

  • Sentenac S, Fernandez C, Thuillier A, Lechat P, Aymard G. Sensitive determination of TDF in human plasma samples using reversed-phase liquid chromatography. Journal of Chromatography B. 2003 Aug 15; 793(2):317-324. https:// doi.org/10.1016/S1570-0232(03)00333-7.

  • Kandagal PB, Manjunatha DH, Seetharamappa J, Kalanur SS. RP‐HPLC method for the determination of TDF in pharmaceutical formulations and spiked human plasma. Analytical Letters. 2008 Mar 1; 41(4):561-570. https://doi.org/10.1080/00032710801910742.

  • Gorja A, Bandla J. Method development and validation for the simultaneous estimation of Lamivudine and TDF disoproxil fumarate in pharmaceutical dosage forms by RP-HPLC. International Journal of Advanced Research in Pharmaceutical and Biomedical Sciences. 2011; 2(1):22-32.

  • Kavitha KY, Geetha G, Hariprasad R, Venkatnarayana R, Subramanian G. Development and validation of RP-HPLC analytical method for simultaneous estimation of Emtricitabine, Rilpivirine, TDF Disoproxil Fumarate and Its pharmaceutical dosage forms. Pharmacie Globale. 2013; 4(1):1.

  • Mali S.A, Salunke P. A, Barhate S.D., Bari M.M. Development and validation of simultaneous RP-HPLC. World Journal of Pharmaceutical Research. 2015; 4(3):995-1006.

  • Nevase PA, Nimje HM, Oswal RJ, Antre RV, Kshirsagar SS. UV spectrophotometric method for estimation of TDF disoproxil fumarate tablet dosage form. Int. J. Pharm. Res. Dev. 2011; 3:73-75. https://doi.org/10.4103/22294708.103876. PMid: 23781482, PMCid: PMC3658085.

  • Gnanarajan G, Gupta AK, Juyal V, Kumar P, Yadav PK, Kailash P. A validated method for development of TDF as API and tablet dosage forms by UV spectroscopy. Journal of Young Pharmacists. 2009 Oct 1; 1(4):351. https://doi.org/10.4103/0975-1483.59326.

  • Anees MI, Baig MS. Determination of lamivudine and TDF in pharmaceutical dosage form by simultaneous and Q-Analysis UV-Spectrophotometric method. WJPPS. 2015; 4(3):688-696.

  • Takahashi M, Kudaka Y, Okumura N, Hirano A, Banno K, Kaneda T. Determination of plasma TDF concentrations using a conventional LC-MS method. Biological and Pharmaceutical Bulletin. 2007 Sep 1; 30(9):1784-1786. https://doi.org/10.1248/bpb.30.1784. PMid: 17827740.

  • Rao J, Gondkar S, Yadav S. Simultaneous HPTLCDensitometric analysis of TDF and Emtricitabine in tablet dosage form. Int. J. Pharm. Tech. Res. 2011; 3(3):1430-1434.

  • 21. Reddy CS, Khan KA, Nagaraja C. A Review on the determination of melting point measurement system. International Journal of Advanced Research in Electrical, Electronics and Instrumentation Engineering. 2016; 5(2):975-979.

  • Bunaciu AA, Aboul-Enein HY, Fleschin S. Recent applications of fourier transform infrared spectrophotometry in herbal medicine analysis. Applied Spectroscopy Reviews. 2011 Apr 19; 46(4):251-260. https://doi.org/10.1080/05704928.2011.565532.

  • Savjani KT, Gajjar AK, Savjani JK. Drug solubility: importance and enhancement techniques. ISRN Pharmaceutics. 2012 Jul 5. https://doi.org/10.5402/2012/195727. PMid: 22830056, PMCid: PMC3399483.

  • Majumder M, Gopinath B, Koni G, Singh SK. New spectrophotometric determination of tinofovir in bulk and pharmaceutical dosage form. Journal of Chemistry. 2009; 6(2):537-540. https://doi.org/10.1155/2009/796402.

  • Ghorpade SA, Sali MS, Kategaonkar AH, Patel DM, Choudhari VP, Kuchekar BS. Simultaneous determination of emtricitabine and TDF by area under curve and dual wavelength spectrophotometric method. Journal of the Chilean Chemical Society. 2010; 55(1):115-117. https://doi.org/10.4067/S0717-97072010000100027.

  • Venkatesan S, Kannappan N. Simultaneous spectrophotometric method for determination of emtricitabine and TDF disoproxil fumarate in three-component tablet formulation containing rilpivirine hydrochloride. International Scholarly Research Notices. 2014. https:// doi.org/10.1155/2014/541727. PMid: 27379309, PMCid: PMC4897216.

  • Nevase PA, Nimje HM, Oswal RJ, Antre RV, Kshirsagar SS. UV Spectrophotometric method for estimation of TDF disoproxil fumarate tablet dosage form. Int. J. Pharm.Res. Dev. 2011; 3:73-75. https://doi.org/10.4103/22294708.103876. PMid: 23781482, PMCid: PMC3658085.

  • Rao J, Gondkar S, Yadav S. Simultaneous HPTLCDensitometric analysis of TDF and emtricitabine in tablet dosage form. Int. J. Pharm. Tech. Res. 2011; 3(3):1430-1434.

  • Djerada Z, Feliu C, Tournois C, Vautier D, Binet L, Robinet A, Marty H, Gozalo C, Lamiable D, Millart H. Validation of a fast method for quantitative analysis of elvitegravir, raltegravir, maraviroc, etravirine, TDF, boceprevir and 10 other antiretroviral agents in human plasma samples with a new UPLC-MS/MS technology. Journal of Pharmaceutical and Biomedical Analysis. 2013 Dec 1; 86:100-111. https://doi.org/10.1016/j.jpba.2013.08.002. PMid: 23995753.

  • Pradeep K, Dwivedi SC, Ashok K. Validated HPTLC method for the determination of TDF as bulk drug and in pharmaceutical dosage form. Research Journal of Chemical Sciences. 2011; 2231:606X.

  • Valluru RK, Kumar P, Kilaru NB. High throughput LC-MS/ MS method for simultaneous determination of TDF, lamivudine and nevirapine in human plasma. Journal of Chromatography B. 2013 Jul 15; 931:117-126. https://doi.org/10.1016/j.jchromb.2013.05.008. PMid: 23774246.

  • Devrukhakar PS, Borkar R, Shastri N, Surendranath KV. A validated stability-indicating RP-HPLC method for the simultaneous determination of TDF, emtricitabine, and a efavirenz and statistical approach to determine the effect of variables. ISRN Chromatography. 2013 Jan 28; 2013.

  • https://doi.org/10.1155/2013/878295.

  • Sharma T, Mishra N, Moitra SS, Sankar DG. A validated RP-HPLC method for estimation of TDF disoproxil fumarate in bulk and pharmaceutical formulation. Asian J.Pharm. Clin. Res. 2012; 5(3):108-110.

  • Purnima BV, Reddy TV, Rao YS, Ramu G, Ramachandran D. Stability indicating RP-UPLC method for assay of Emtricitabine and TDF Disoproxil Fumarate in bulk and dosage forms. American Journal of Analytical Chemistry. 2015; 6(10):807. https://doi.org/10.4236/ajac.2015.610077.

  • Hussen SS, Shenoy P, Krishna M. Development and validation of stability indicating RP-HPLC method for TDF nanoparticle formulation. Int. J. Pharm. Pharm. Sci. 2013; 5(2):245-248.

  • Nadig S, Jacob JT, Bhat I, Kishoreraju V. A stability indicating RP-HPLC method for simultaneous estimation of Emtricitabine, TDF disoproxil fumarate and Efavirenz in pharmaceutical dosage forms. International Journal of Research in Pharmaceutical Sciences. 2013 Jul 15; 4(3):391-396.


Abstract Views: 290

PDF Views: 102




  • Method Development and Validation for Estimation of Tinofovir Disoproxil Fumarate in Pharmaceutical Preparation by UV-Spectroscopy and HPLC with Force Degradation Study

Abstract Views: 290  |  PDF Views: 102

Authors

Bhushan Ashok Bhairav
Department of Pharmaceutical Sciences, Mewar University, Chittorgarh − 312901, Rajasthan, India
Machhindra Jayram Chavan
Amrutvahini College of Pharmacy, Savitribai Phule Pune University, Pune − 422605, Maharashtra, India

Abstract


Tinofovir Disoproxil Fumarate (TDF) is an acyclic nucleotide diester analog of adenosine monophosphate from the antiviral category utilized in the AIDS and hepatitis B treatment. In the present study, two analytical methods, i.e. UV and HPLC were developed for the TDF’s estimation in pharmaceutical preparation. In the UV method, the mobile phase used was Methanol and water in 60:40 ratio for estimation of the drug at 260 nm and an assay of the (TDF) obtained was 99.53%. The method’s validation was carried out as per ICH Q2 R1 guidelines in which linearity was detected from 10-50 µg/ml range with a regression value of 0.999 Percent RSD value of accuracy, precision and robustness were below 2. In the HPLC method estimation of (TDF) was evaluated on Cosmosil C-18 (250mm×4.6ID, Particle size: 5 µ) column utilizing Methanol: Water (60:40), 0.9 ml/min of flow rate, detection wavelength was 260 nm and the time of retention observed was around 4.63 minutes with the assay value 99.07%. HPLC method was also validated according to ICH guidelines, where linearity was detected in the 10-50 μg/ml of range with the regression coefficient value 0.999. The % RSD of precision, accuracy, and robustness was below 2%. The study of forced degradation was also performed by the HPLC method utilizing methanol: water (60:40) at 260nm. From this study, it can be concluded that the developed methods for estimation of (TDF) drug in pharmaceutical preparation are simple, accurate, precise, and can be utilized in the routine analysis for quantification of the drug in a dosage form.


Keywords


Force Degradation Study, HPLC, Tinofovir Disoproxil Fumarate, UV, Validation

References





DOI: https://doi.org/10.18311/ajprhc%2F2021%2F26050